Karina Abramov (Karina Abramov-Harpaz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Oxide Nanoparticles

Top Venues

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Carmia Blacher, Karina Abramov, Yifat Miller
Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site. Biomolecules 14 (6) (2024)
Carmia Blacher, Karina Abramov, Yifat Miller
Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site. Biomolecules 14 (6) (2024)
Carmia Blacher, Karina Abramov, Yifat Miller
Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site. Biomolecules 14 (6) (2024)
Karina Abramov, Yifat Miller
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12 (12) (2022)
Milica Markovic, Shimon Ben-Shabat, Jagadeesh Nagendra Manda, Karina Abramov, Clil Regev, Yifat Miller, Aaron Aponick, Ellen M Zimmermann, Arik Dahan
PLA 2 -Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics 14 (3) (2022)
Karina Abramov, Yifat Miller
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12 (12) (2022)
Karina Abramov, Yifat Miller
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12 (12) (2022)
Milica Markovic, Karina Abramov, Clil Regev, Shimon Ben-Shabat, Aaron Aponick, Ellen M Zimmermann, Yifat Miller, Arik Dahan
Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA 2 -Mediated Activation. International journal of molecular sciences 23 (5) (2022)
Karina Abramov, Yifat Miller
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12 (12) (2022)
Karina Abramov, Yifat Miller
Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12 (12) (2022)
Shlomit Odes-Barth, Marina Khanin, Karin Linnewiel-Hermoni, Yifat Miller, Karina Abramov, Joseph Levy, Yoav Sharoni
Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-ƙB Pathway. Antioxidants (Basel, Switzerland) 9 (11) (2020)